CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






L - threo - D - galacto - Octopyranoside, methyl 7 - chloro - 6,7,8 - trideoxy - 6 - (1 - methyl - 4 - propyl - L - 2 - pyrrolidinecarboxamido) - 1 - thio - , trans - alpha -

RTECS #: RH6300000

CAS #: 18323-44-9


UPDATE: May 2009 MW: 425.04 MF: C18H33ClN2O5S


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. ACUTE TOXICITY DATA:
  3. OTHER MULTIPLE DOSE DATA:
  4. REVIEWS:
  5. NIOSH DOCUMENTATION AND SURVEILLANCE:
  6. REFERENCES:

SYNONYMS:

  1. 7 (S) - Chloro - 7 - deoxylincomycin
  2. 7 - CDL
  3. 7 - Chlorodeoxylincomycin
  4. 7 - Chlorolincomycin
  5. Chlolincocin
  6. Cleocin
  1. Clindamycin
  2. Clindamycine (French)
  3. Clinimycin
  4. Dalacin C
  5. Sobelin
  6. U - 21,251


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
N/R N/R N/R N/R


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
mouse
lethal dose (50 percent kill): 1,100 mg/kg N/R VCVPS* -,408,1998
intramuscular
rat
lethal dose (50 percent kill): 3,500 mg/kg N/R VCVPS* -,408,1998
intraperitoneal
mammal (species unspecified)
lethal dose (50 percent kill): 262 mg/kg N/R VCVPS* -,408,1998
intraperitoneal
mouse
lethal dose (50 percent kill): 361 mg/kg N/R VCVPS* -,408,1998
intraperitoneal
rat
lethal dose (50 percent kill): 745 mg/kg N/R VCVPS* -,408,1998
intravenous
mammal (species unspecified)
lethal dose (50 percent kill): 143 mg/kg N/R VCVPS* -,408,1998
intravenous
mouse
lethal dose (50 percent kill): 245 mg/kg N/R VCVPS* -,408,1998
intravenous
rabbit
lowest published toxic dose: 5 mg/kg Vascular: BP lowering not characterized in autonomic section VCVPS* -,408,1998
oral
hamster
lowest published lethal dose: 1 mg/kg Gastrointestinal: Other changes ARZNAD 34,794,1984
oral
mammal (species unspecified)
lethal dose (50 percent kill): 5,000 mg/kg N/R VCVPS* -,408,1998
oral
mouse
lethal dose (50 percent kill): 2,540 mg/kg N/R VCVPS* -,408,1998
oral
rat
lethal dose (50 percent kill): 2,190 mg/kg N/R VCVPS* -,408,1998
oral
rabbit
lowest published lethal dose: 1 mg/kg N/R RMVEAG 156,915,1980
subcutaneous
rat
lethal dose (50 percent kill): 2,618 mg/kg N/R TXAPA9 18,185,1971


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
oral
human
lowest published toxic dose: 89.6 mg/kg/7 day- intermittent Gastrointestinal: Hypermotility, diarrhea

Gastrointestinal: Nausea or vomiting
VCVPS* -,408,1998
oral
human
lowest published toxic dose: 60.2 mg/kg/7 day- intermittent Gastrointestinal: Hypermotility, diarrhea

Gastrointestinal: Other changes
VCVPS* -,409,1998
oral
human
lowest published toxic dose: 90 mg/kg/7 day- intermittent Skin: After systemic exposure: Dermatitis, allergic BJDEAZ 146,643,2002
oral
rat
lowest published toxic dose: 4,200 mg/kg/2 week- intermittent Blood: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
VCVPS* -,408,1998
oral
rat
lowest published toxic dose: 210 mg/kg/3 week- intermittent Blood: Other changes

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases

Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
VCVPS* -,408,1998
oral
rat
lowest published toxic dose: 210 mg/kg/3 week- intermittent Blood: Change in clotting factors VCVPS* -,408,1998
oral
rabbit
lowest published toxic dose: 330 mg/kg/33 day- intermittent Gastrointestinal: Other changes ANTBAL 28,18,1983


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

TOXICOLOGY REVIEW
MUREAV 488,151,2001
TOXICOLOGY REVIEW
TOLED5 142,207,2003
TOXICOLOGY REVIEW
EMMUEG 43,143,2004
TOXICOLOGY REVIEW
EJIME* 17,529,2006
TOXICOLOGY REVIEW
DIMON* 39,678,1993
TOXICOLOGY REVIEW
HPCQA4 38,527,2007


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: X3191;
Number of Industries 1;
Total Number of Facilities 445;
Number of Occupations 7;
Total Number of Employees Exposed 21,575;
Total Number of Female Employees Exposed 17,442


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

N/R


REFERENCES:

CODEN
REFERENCE

ANTBAL Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH.
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951-
BJDEAZ British Journal of Dermatology. (Blackwell Scientific Pub. Ltd., POB 88, Oxford, UK) V.63- 1951-
DIMON* Disease-a Month (Chicago : Year Book Publishers) V. 24- 1978-
EJIME* European Journal of Internal Medicine: The Official Journal of the European Federation of Internal Medicine (EFIM) (Elsevier) V.10- 1999-
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987-
HPCQA4 Human Pathology. (W.B. Saunders Co., W. Washington Sq., Philadelphia, PA 19105) V.1- 1970-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
RMVEAG Recueil de Medecine Veterinaire. (Masson Pub. USA, Inc., Year Book Medical Pub., 35 E. Wacker Dr., Chicago IL 60601) V.1- 1824-
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977-
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959-
VCVPS* "Vrednie chemichescie veshestva. Prirodnie organicheskie soedinenia" (Hazardous substances. Nature products.) Volkova N.V. et al., Sankt-Peterburg, 1998.

RTECS Compound Description:
   Drug
   Human Data
   Natural Product

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us